Clinical Trial Update: Subcutaneous Nitroglycerin to Facilitate Trans-radial Access. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating subcutaneous nitroglycerin to facilitate trans-radial access in coronary artery disease is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• NITROGLYCERIN (Nitroglycerin)

Snippet

Sponsor: Instituto Nacional de Cardiologia Ignacio Chavez | Conditions: Coronary Artery Disease | Phase 4 | Status: SUSPENDED